Provided by Tiger Trade Technology Pte. Ltd.

Mirum Pharmaceuticals, Inc.

88.51
-2.2100-2.44%
Post-market: 88.510.00000.00%19:16 EDT
Volume:2.23M
Turnover:197.92M
Market Cap:5.34B
PE:-188.32
High:91.70
Open:90.73
Low:86.90
Close:90.72
52wk High:109.28
52wk Low:36.88
Shares:60.34M
Float Shares:39.99M
Volume Ratio:2.62
T/O Rate:5.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4700
EPS(LYR):-0.4700
ROE:-8.65%
ROA:-1.83%
PB:16.97
PE(LYR):-188.32

Loading ...

Baird Adjusts Mirum Pharmaceuticals Price Target to $95 From $88, Maintains Outperform Rating

MT Newswires Live
·
Jan 13

BRIEF-Mirum Pharmaceuticals Announces Preliminary Unaudited 2025 Results, Demonstrating Strong Commercial Growth And Pipeline Momentum

Reuters
·
Jan 12

Mirum Pharmaceuticals Projects 2026 Global Net Product Sales of Up to $650 Million

Reuters
·
Jan 12

Mirum Pharmaceuticals Inc - Livmarli Expand Study in Additional Cholestatic Pruritus Settings Timing Accelerated; Topline Data NOW Expected Q4 2026

THOMSON REUTERS
·
Jan 12

Mirum Pharmaceuticals Inc - Prelim 2025 Net Product Sales of Approximately $520 Mln Exceed Upper End of Guidance

THOMSON REUTERS
·
Jan 12

Mirum Pharmaceuticals Inc - Volixibat Vistas Study in Primary Sclerosing Cholangitis (Psc) Topline Data Expected Q2 2026

THOMSON REUTERS
·
Jan 12

Mirum Pharmaceuticals - Bluejay Therapeutics' Azure-1 Study in Hdv Interim Data Expected in Q2 2026, Topline Phase 3 Data Expected in H2 2026

THOMSON REUTERS
·
Jan 12

Is Mirum Pharmaceuticals (MIRM) Quietly Reframing Its Orphan-Drug Identity With the BLOOM Fragile X Trial?

Simply Wall St.
·
Jan 12

Is It Too Late To Consider Mirum Pharmaceuticals (MIRM) After A 95% One-Year Rally?

Simply Wall St.
·
Jan 09

Director Saira Ramasastry Reports Disposal of Mirum Pharmaceuticals Inc. Common Shares

Reuters
·
Dec 24, 2025

Mirum Pharmaceuticals Director Michael G. Grey Reports Disposal of Common Shares

Reuters
·
Dec 24, 2025

Mirum Pharmaceuticals Inc - Files Patent Infringement Suits Against Anda Filers - SEC Filing

THOMSON REUTERS
·
Dec 20, 2025

Director Saira Ramasastry Sells Common Shares of Mirum Pharmaceuticals Inc

Reuters
·
Dec 20, 2025

Mirum Pharmaceuticals Sues Generic Drugmakers Over Livmarli Patent Infringement

Reuters
·
Dec 20, 2025

Mirum Pharmaceuticals Agrees to $68.5 Million Equity Private Placement

MT Newswires Live
·
Dec 19, 2025

BRIEF-Mirum Pharmaceuticals Announces Additional Private Placement Financing With Tcgx

Reuters
·
Dec 19, 2025

Mirum Pharmaceuticals Is Maintained at Market Outperform by Citizens

Dow Jones
·
Dec 19, 2025

Mirum Pharmaceuticals Inc - Private Placement of 1 Mln of Commons Tock at $68.48 per Share

THOMSON REUTERS
·
Dec 19, 2025

Mirum Pharmaceuticals Grants Stock Options and RSUs to New Employees

Reuters
·
Dec 11, 2025

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Dec 11, 2025